Joseph Todisco - 15 Nov 2022 Form 4 Insider Report for CorMedix Inc. (CRMD)

Role: Chief Executive Officer, Director
Signature: /s/ Joseph Todisco
Issuer symbol: CRMD
Transactions as of: 15 Nov 2022
Net transactions value: +$76,400
Form type: 4
Filing time: 16 Nov 2022, 15:56:28 UTC
Previous filing: 25 Aug 2022
Next filing: 18 Jan 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CRMD	Common Stock	Purchase	$76,400	+20,000	+9%	$3.82	242,169	15 Nov 2022	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.77 to $3.85, inclusive. The reporting person undertakes to provide CorMedix Inc., any security holder of CorMedix Inc., or the staff at the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4.

Content

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.77 to $3.85, inclusive. The reporting person undertakes to provide CorMedix Inc., any security holder of CorMedix Inc., or the staff at the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4.